Back

Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India

29 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Lipids (1) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kunal Mahajan

Himachal Heart Institute, Mandi (India)

4 More presentations in this session

Presentation thumbnail
Predictive value of blood count derived inflammatory markers for LDL cholesterol target achievement after STEMI
Doctor V. Halatiu (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Treatment quality in patients with familial hypercholesterolemia in Denmark
Doctor J. Knold (Odense, DK)
Abstract Slides Video
Presentation thumbnail
The SLCO1B1 c.521 T > C variant is not associated with muscular symptoms or PCSK9-inhibitor prescription in patients with severe hypercholesterolemia
Doctor L. Galli (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Early post-discharge follow-up improves lipid control and reduces cardiovascular risk in ACS patients: insights from a tertiary cardiac centre
Doctor A. Elkammash (Bristol, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipid lowering therapy and the unmet targets in Indian patients with angiographically proven coronary artery disease: results from the OLS registry
thumbnail
Congress Presentation
Attainment of LDL-cholesterol goals in patients with previous myocardial infarction: a real-world cross-sectional analysis
thumbnail
Congress Presentation
Unmet needs of LDL C lowering in ACS patients when using only high intensity statins puts at setback

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources